Oncocyte Announces August Investor Conferences Participation
IRVINE, Calif., August 5, 2024 — Oncocyte Corp. (Nasdaq: OCX), a molecular diagnostics technology company, today announced that CEO Josh Riggs and CFO Andrea James plan to participate in the following investor conferences in August: 9th Annual Needham Virtual MedTech...
BioStem Technologies to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024
Conference Call and Webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., August 5, 2024, — BioStem Technologies, Inc. (OTC: BSEM), a leading medtech company specializing in the development, manufacture, and commercialization of placental-derived allografts for...
Vocodia Holdings Announces $2.8 million Preferred Stock Purchase Agreement as part of a $3.0 million Capital Raise
Boca Raton, FL, August 5, 2024 – Vocodia Holdings Corp (CBOE: VHAI) (“Vocodia” or the "Company") a leader in AI software development focusing on practical AI applications, today announced the execution of a Securities Purchase Agreement (the “SPA”) and a Placement...
Direct Equity Source Announces Strategic Partnership with AAA Storage to Expand Self-Storage Portfolio
Austin, Texas, August 2, 2024 – Direct Equity Source, a leading real estate private equity firm, is pleased to announce a strategic partnership with AAA Storage, an industry-leading self-storage company. Direct Equity Source, via its recently formed fund, will be the...
Vocodia’s Demos Offer Human-Like AI Interactions
Chicago, August 2, 2024 -- Vocodia Holdings Corp. (CBOE: VHAI), a pioneering AI software company specializing in practical AI solutions, today invites the public to try out one of four groundbreaking Conversational AI demos to see how Vocodia’s Digital Intelligent...
Lipella Pharmaceuticals Announces Closing of $1.28 Million Registered Direct Offering of Common Stock Priced At-the-Market Under Nasdaq Rules
PITTSBURGH, PA, August 1, 2024 – Lipella Pharmaceuticals Inc. (“Lipella” or the “Company”) (Nasdaq: LIPO), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announced that it has closed its previously announced...
Oncocyte to Announce Second Quarter 2024 Financial Results on August 8
Conference Call and Webcast on Thursday, August 8, 2024 at 2:00 p.m. PT / 5:00 p.m. ET IRVINE, Calif., Aug 1, 2024 - Oncocyte Corp. (Nasdaq: OCX), a diagnostics technology company, announced today that the company will release its second quarter 2024 financial results...
SPZI: Bloxcross and JP3E Announce the Global Trade Financing Platform Is Live
NEW YORK, August 1, 2024 - JP 3E Holdings, Inc. (OTC: SPZI), formerly Spooz, Inc., recently acquired a majority stake in Bloxcross, Inc. In the wake of this significant acquisition, they announce the launch of a new Global Trade Financing Platform, positioning...
Lipella Pharmaceuticals Announces $1.28 Million Registered Direct Offering of Common Stock Priced At-the-Market Under Nasdaq Rules
PITTSBURGH, PA, August 1, 2024 – Lipella Pharmaceuticals Inc. (“Lipella” or the “Company”) (Nasdaq: LIPO), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announced that it has entered into a definitive agreement...
PRISM MarketView Launches AI Infrastructure and Datacenter Index
New Index Showcases Companies Positioned to Fuel the Booming AI Market NEW YORK, August 01, 2024-- PRISM MarketView, a leading provider of unbiased market insight and company news, today announces the launch of its PRISM Emerging AI Infrastructure and Datacenter Index...